JavaScript is disabled. Please enable to continue!
Mobile search icon
Bio/Pharma Product Testing Services >> Gene and Cell Therapy >> Raw Materials Testing

Raw Materials Testing for Cell & Gene Therapy Manufacturing

Sidebar Image

Raw Materials TestingEurofins BioPharma Product Testing is well versed in evaluating critical quality attributes (CQAs) of a diverse range of ancillary and raw materials, including monographed and non-monographed materials, used in cell and gene therapy products. Using established GMP methods, platform techniques, and customized methods, Eurofins provides robust, flexible, and high throughput lot release testing for the fast-paced manufacturing of today’s therapies.

Our dedicated Biologics Raw Materials testing team has vast experience in cell and gene therapy manufacturing from early clinical, through process validation, product optimization, and marketed release. With 20 years of biopharmaceutical experience, our teams of scientists have current and relevant expertise in marketed and clinical chimeric antigen (CAR-T) and T-cell receptor (TCR) therapies, as well as manufacturing support for a broad array of viral and plasmid vector modalities. This allows us to immediately leverage impactful knowledge in materials used in apheresis, fractionation, cell selection, activation, gene transfer, expansion, and cryopreservation of cell therapy products as well as transfection, vector production, and purification of gene products.

Why Choose Eurofins BioPharma Product Testing?

  • We provide a comprehensive raw materials testing package to support all testing needs.
  • We can develop and validate unique methods to test biologic materials as well as support platform methods for many of the techniques offered.
  • We have the ability to test non-monographed materials to satisfy agency scrutiny.
  • Our secure, 24/7 online data portal, LabAccess.com, provides timely access to your test results.

Biologic Raw Material Testing Capabilities

Chemically Defined Growth Media

  • Identification and content by amino acid analysis
  • Platform pH and osmolality
  • Vitamin and sugar content
  • Growth promotion assays
  • Microbiological services

Process Buffers, Cryopreservation Solutions, and Chemical Transfection Agents

  • Ion identification (wet chemistry, IC and ICP-MS)
  • Platform pH, conductivity, osmolality
  • Platform protease, RNase, and DNase detection
  • Platform content procedures – titrations, HPLC, GC

Cytokines, Growth Factors, Enzymes, etc.

  • Enzyme activity assays and kinetics
  • Identification and content by ELISA, Western Blot or other electrophoretic methods
  • Total protein
  • Purity, oligomers and aggregation (SDS-PAGE, SEC, GPC)
  • Microbiological services
  • Cell based potency and cytotoxicity assays